International AIDS Society
International AIDS Society
 
 
   

Industry Liaison Forum


The Industry Liaison Forum (ILF) is an initiative of the International AIDS Society (IAS) with a mission to accelerate scientifically promising, ethical HIV research in resource-limited countries, with a particular focus on the role and responsibilities of industry as sponsors and supporters of research.



IAS-ILF and 15 other leading public and private sector organizations released a comprehensive research agenda designed to significantly advance global responses to HIV in women, girls and children.

The new consensus statement, Asking the Right Questions: Advancing an HIV Research Agenda for Women and Children, includes 20 specific recommendations to expand and improve responses to the HIV-related challenges facing women and children worldwide.

Read the related press release 


What's New


New ILF Strategic Plan 2012-2014
The new strategic plan outlining ILF’s priorities for the next three years was adopted at IAS 2011, and is available for viewing and download.


Gender in Editorial Policy

In line with the ILF's Consensus Statement recommendation that research data should be disaggregated by sex, we would like to congratulate The Lancet for adopting the Editorial Gender Policy. Notably, the Journal of the International AIDS Society (JIAS) introduced this policy earlier this year. Read more about the policy here: http://jiasociety.org/content/14/1/11.


IAS 2011 Session Reports

Challenges in the Procurement and Development of Paediatric Antiretroviral Formulations

What does the future of ARV-based prevention look like?

Operational and Implementation Challenges in Scaling Up PMTCT Programmes in Resource-­‐Limited Settings


10 Years of ILF



Read the related press release


 

  FaceBook Twitter
HIV/Industry News

25 November 2011
VOICE Trial Team Announces Closure of Tenofovir Gel Trial Arm in VOICE Trial

21 September 2011
Viramune® (nevirapine) prolonged-release once-daily formulation for the treatment of HIV-1 infection receives approval in the EU

21 March 2011
Despite great strides, more is needed in pediatric AIDS research
Laura Guay (Elizabeth Glacer Pediatric AIDS Foundation)


8 March 2011
Time for gender mainstreaming in editorial policies

27 January 2011
Tibotec signs multiple agreements with generic manufacturers to provide access to new HIV treatment

Articles from previous years are available here


2011 Sponsoring Industry Partners

Abbott
 
Boehringer Ingelheim
 
Gilead
 
 Merck
Merck & Co., Inc.
 
Roche
 
Tibotec
 
 Viiv Healthcare